CVE-2026-65932: Silabs.com BT122

Medium severity, CVSS 5.3. EPSS: 0.3% chance of exploitation in the next 30 days.

The BT122 module stops advertising after receiving a plaintext 'pause enceryption response' message resulting in a denial of service. See vulnerability B-E2 in the related paper below.

Affected products

• Silabs.com BT122: up to and including 1.4.0

Published 2026-08-13. Last modified 2026-09-08.